US companies SandboxAQ and iOncologi have announced a strategic collaboration to jointly develop, validate, and commercialize ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

Sweden’s OncoZenge has announced an amendment to its license and supply agreement with Italian firm Molteni Farmaceutici.

Swiss pharma giant Roche has won approval from the UK’s Medicines and Healthcare Regulatory Agency (MHRA) for its combination ...

UK pharma major GSK has gained US regulatory approval for a new prefilled syringe presentation of its shingles vaccine, ...

Artificial intelligence has edged past the pilot phase in clinical development. Once a niche add-on, AI is now helping ...

Bayer (BAYN: DE) is giving chief executive Bill Anderson more time to deliver on his ambitious efforts to reshape the German ...

Swiss pharma giant Novartis this morning reported second quarter 2025 financial results, showing that net sales were $14.1 ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Kisqali (ribociclib) as an ...

US rare disease meds developer Sarepta Therapeutics late yesterday announced a strategic restructuring plan designed to ...

Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no ...

UK pharma major GSK is seeking US approval for Blenrep (belantamab mafodotin) in two multiple myeloma indications.